| |
| |
|
| Insider
Information: |
Izzar Rachid |
| Relationship: |
Head of Global Product... |
| City: |
Cambridge |
| State: |
MA |
| |
|
| Insider
Summary: |
|
|
|
|
Companies Owned : |
1 |
|
| Direct
Shares |
9,701 |
|
|
Indirect Shares
|
0 |
|
|
| Direct
Value |
$2,026,539 |
|
|
|
Indirect Value
|
$0 |
|
|
| Total
Shares |
9,701 |
|
|
| Total
Value |
$2,026,539 |
|
|
|
|
|
|
|
|
Historical
Performance :
Based on 6 Month Return Percentages |
Buys
|
Sells
|
|
Total
Filings :
|
0
|
0
|
|
Stock
price went up :
|
|
|
| Stock
price went down : |
|
|
| |
|
|
|
Gain/Loss Ratio : |
0.0
|
0.0
|
| Percentage
Gain/Loss : |
0.0%
|
0.0%
|
| |
|
|
|
|
|
Holdings
:
| Menu |
Company Name |
Ticker |
Relation |
Direct Date |
Direct Shares |
Indirect Date |
Indirect Shares |
Total Value Sold  |
 |
Biogen Idec Inc |
BIIB |
Head of Global Product... |
2024-02-16 |
9,701 |
2021-12-02 |
0 |
Premium* |
|
|
|
|
|
|
|
|
|
|
|
Records found :
23 |
Free Registration Required For Full Results. Limit: 25
|
 |
Download |
Page 1 of 1
|
| Ticker |
Company Name |
Relation |
Off-Dir-10% |
Trans. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
| 3m +/- |
|
|
Form |
| BIIB |
Biogen Idec Inc |
Head of Global Product Strat. |
• • – |
2024-02-16 |
4 |
D |
$219.08 |
$208,564 |
D/D |
(952) |
9,701 |
0 |
- |
|
| BIIB |
Biogen Idec Inc |
Head of Global Product Strat. |
• • – |
2024-02-16 |
4 |
OE |
$0.00 |
$0 |
D/D |
2,017 |
10,014 |
0 |
- |
|
| BIIB |
Biogen Idec Inc |
Head of Global Product Strat. |
• • – |
2024-02-09 |
4 |
D |
$240.98 |
$107,236 |
D/D |
(445) |
8,636 |
0 |
- |
|
| BIIB |
Biogen Idec Inc |
Head of Global Product Strat. |
• • – |
2024-02-09 |
4 |
OE |
$0.00 |
$0 |
D/D |
1,515 |
9,081 |
0 |
- |
|
| BIIB |
Biogen Idec Inc |
Head of Global Product Strat. |
• • – |
2024-02-08 |
4 |
OE |
$0.00 |
$0 |
D/D |
2,043 |
8,187 |
0 |
- |
|
| BIIB |
Biogen Idec Inc |
Head of Global Product Strat. |
• • – |
2024-02-08 |
4 |
D |
$240.30 |
$149,226 |
D/D |
(621) |
7,566 |
0 |
- |
|
| BIIB |
Biogen Idec Inc |
Head of Global Product Strat. |
• • – |
2023-06-30 |
4 |
D |
$284.85 |
$69,503 |
D/D |
(244) |
6,144 |
0 |
- |
|
| BIIB |
Biogen Idec Inc |
Head of Global Product Strat. |
• • – |
2023-06-30 |
4 |
OE |
$0.00 |
$0 |
D/D |
504 |
6,388 |
0 |
- |
|
| BIIB |
Biogen Idec Inc |
Head of Global Product Strat. |
• • – |
2023-02-17 |
4 |
D |
$278.38 |
$103,279 |
D/D |
(371) |
5,117 |
0 |
- |
|
| BIIB |
Biogen Idec Inc |
Head of Global Product Strat. |
• • – |
2023-02-17 |
4 |
OE |
$0.00 |
$0 |
D/D |
767 |
5,884 |
0 |
- |
|
| BIIB |
Biogen Idec Inc |
Head of Global Product Strat. |
• • – |
2023-02-10 |
4 |
D |
$286.30 |
$379,061 |
D/D |
(1,324) |
5,488 |
0 |
- |
|
| BIIB |
Biogen Idec Inc |
Head of Global Product Strat. |
• • – |
2023-02-10 |
4 |
OE |
$0.00 |
$0 |
D/D |
1,968 |
6,350 |
0 |
- |
|
| BIIB |
Biogen Idec Inc |
Head of Alzheimers Disease |
• • – |
2023-01-25 |
4 |
A |
$0.00 |
$0 |
D/D |
1,783 |
4,844 |
0 |
- |
|
| BIIB |
Biogen Idec Inc |
Head of Alzheimers Disease |
• • – |
2022-12-02 |
4 |
D |
$298.90 |
$226,865 |
D/D |
(759) |
3,061 |
0 |
- |
|
| BIIB |
Biogen Idec Inc |
Head of Alzheimers Disease |
• • – |
2022-12-02 |
4 |
OE |
$0.00 |
$0 |
D/D |
1,710 |
3,250 |
0 |
- |
|
| BIIB |
Biogen Idec Inc |
Head of Alzheimers Disease |
• • – |
2022-07-01 |
4 |
D |
$210.63 |
$31,173 |
D/D |
(148) |
2,110 |
0 |
- |
|
| BIIB |
Biogen Idec Inc |
Head of Alzheimers Disease |
• • – |
2022-07-01 |
4 |
OE |
$0.00 |
$0 |
D/D |
504 |
2,258 |
0 |
- |
|
| BIIB |
Biogen Idec Inc |
Head of Alzheimers Disease |
• • – |
2022-02-18 |
4 |
OE |
$0.00 |
$0 |
D/D |
594 |
1,929 |
0 |
- |
|
| BIIB |
Biogen Idec Inc |
Head of Alzheimers Disease |
• • – |
2022-02-18 |
4 |
D |
$209.79 |
$36,713 |
D/D |
(175) |
1,754 |
0 |
- |
|
| BIIB |
Biogen Idec Inc |
Head of Alzheimers Disease |
• • – |
2022-02-12 |
4 |
D |
$214.59 |
$26,180 |
D/D |
(122) |
1,335 |
0 |
- |
|
| BIIB |
Biogen Idec Inc |
Head of Alzheimers Disease |
• • – |
2022-02-12 |
4 |
OE |
$0.00 |
$0 |
D/D |
351 |
1,457 |
0 |
- |
|
| BIIB |
Biogen Idec Inc |
Head of Alzheimers Disease |
• • – |
2021-12-02 |
4 |
D |
$228.52 |
$37,706 |
D/D |
(165) |
1,106 |
0 |
- |
|
| BIIB |
Biogen Idec Inc |
Head of Alzheimers Disease |
• • – |
2021-12-02 |
4 |
OE |
$228.52 |
$85,009 |
D/D |
372 |
1,271 |
0 |
- |
|
23 Records found
|
1
|
Page 1 of 1 |
| |
Free Registration Required For Full Results. Limit: 25
|
|
| |
Transaction Code Key: |
Ownership Code Key |
| |
B |
- Buy |
AB |
- Automatic Buy |
D |
- Direct Ownership |
| |
S |
- Sell |
AS |
- Automatic Sell |
I |
- Indirect Ownership |
|
OE |
- Options Exercised |
A |
- Aquired |
| |
IO |
- Initital Ownership |
D |
- Disposed |
| |
|
|
|
|
|
